113 related articles for article (PubMed ID: 1880567)
1. Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors.
Suess E; Malessa S; Ungersböck K; Kitz P; Podreka I; Heimberger K; Hornykiewicz O; Deecke L
J Nucl Med; 1991 Sep; 32(9):1675-81. PubMed ID: 1880567
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow measurements with HMPAO- and HIPDM-SPECT in brain tumors: basic rCBF studies.
Maier-Hauff K; Gerlach L; Baerwald R; Cordes M
Psychiatry Res; 1989 Sep; 29(3):341-2. PubMed ID: 2608790
[No Abstract] [Full Text] [Related]
3. [A case of meningioma with non-accumulation of 99mTc-ECD and increased accumulation of 99mTc-HMPAO in the tumor].
Kashimada A; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Inoue Y
Kaku Igaku; 1992 Sep; 29(9):1127-31. PubMed ID: 1453563
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-HMPAO retention and the role of glutathione: the debate continues.
Babich JW
J Nucl Med; 1991 Sep; 32(9):1681-3. PubMed ID: 1880568
[No Abstract] [Full Text] [Related]
5. Discordant technetium-99m-MIBI and technetium-99m-HMPAO uptake of recurrent occipital meningioma on brain SPECT images.
Shih WJ; Lee JK; Milan P
J Nucl Med; 1996 Jul; 37(7):1183-5. PubMed ID: 8965195
[TBL] [Abstract][Full Text] [Related]
6. Discordant technetium-99m HMPAO and thallium-201 chloride distribution in brain tumors.
Kamisaki Y; Seto H; Nagayoshi T; Kageyama M; Shimizu M; Wu YW; Watanabe N; Kakishita M
Radiat Med; 1996; 14(3):155-8. PubMed ID: 8827811
[TBL] [Abstract][Full Text] [Related]
7. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
8. Investigations of brain tumours with 99Tcm-HMPAO SPECT.
Langen KJ; Roosen N; Herzog H; Kuwert T; Kiwit JC; Bock WJ; Feinendegen LE
Nucl Med Commun; 1989 May; 10(5):325-34. PubMed ID: 2787007
[TBL] [Abstract][Full Text] [Related]
9. Increased technetium-99m-HMPAO uptake in grade II astrocytoma.
Grünwald F; Menzel C; Pietsch T; Pavics L; Hufnagel A; Biersack HJ
J Nucl Med; 1995 May; 36(5):804-6. PubMed ID: 7738652
[TBL] [Abstract][Full Text] [Related]
10. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.
Hirano T; Otake H; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1997 Jan; 38(1):20-6. PubMed ID: 8998143
[TBL] [Abstract][Full Text] [Related]
11. [99mTc-hexamethylpropyleneamine oxime (HMPAO)--its diagnostic potentials for assessing the cerebral blood supply (a review)].
Krotkov FF; Petunina IV
Med Radiol (Mosk); 1989 Nov; 34(11):29-35. PubMed ID: 2685504
[No Abstract] [Full Text] [Related]
12. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
Andersen AR
Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
[TBL] [Abstract][Full Text] [Related]
13. Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.
Woods SW; Hegeman IM; Zubal IG; Krystal JH; Koster K; Smith EO; Heninger GR; Hoffer PB
J Nucl Med; 1991 Feb; 32(2):210-5. PubMed ID: 1992020
[TBL] [Abstract][Full Text] [Related]
14. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
[TBL] [Abstract][Full Text] [Related]
15. [Single photon emission computed tomography using 99mTc-hexamethylpropyleneamine oxime in patients with metastatic brain tumor or intracranial malignant lymphoma].
Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Muranaka A; Furukawa T; Mimura H; Yanagimoto S; Tomomitsu T
Kaku Igaku; 1991 May; 28(5):499-507. PubMed ID: 1886284
[No Abstract] [Full Text] [Related]
16. An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography.
Pupi A; De Cristofaro MT; Bacciottini L; Antoniucci D; Formiconi AR; Mascalchi M; Meldolesi U
J Nucl Med; 1991 Aug; 32(8):1501-6. PubMed ID: 1869968
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
[TBL] [Abstract][Full Text] [Related]
18. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT.
Murase K; Tanada S; Fujita H; Sakaki S; Hamamoto K
J Nucl Med; 1992 Jan; 33(1):135-43. PubMed ID: 1730979
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of 99mTc-HMPAO uptake in cerebral gliomas--a comparison with X-ray CT.
Irvine AT; Flower MA; Ott RJ; Babich JW; Kabir F; McCready VR
Eur J Nucl Med; 1990; 16(4-6):293-8. PubMed ID: 2351177
[TBL] [Abstract][Full Text] [Related]
20. [Single photon emission computed tomography (SPECT) using 99mTc-hexamethylpropyleneamine oxime in brain tumor: comparison of N-isopropyl-[123I]-p-iodoamphetamine and 99mTc-DTPA SPECT].
Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Muranaka A; Furukawa T; Yanagimoto S; Tomomitsu T; Watanabe A
Kaku Igaku; 1988 Dec; 25(12):1371-9. PubMed ID: 3074203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
